​​Cancer Biology Students

   
Page    of 1
  • Molly Brakhane

  • Marlene Campos Guerrero

    Investigating the role of Squamous Cell Carcinoma Antigen 1 (SCCA1), in cervical cancer tumor microenvironment.
  • Julius Chembo

    Discovering and validating pharmacological/ therapeutic inhibitors of NRF2 in Lung, Head and Neck Cancers
  • Pei Yu Chen

    To investigate the role of ARID2 in melanoma.
  • Jessica Devenport

    Investigating the role of APOBEC3A in tumor progression and clonal evolution
  • Rachel DeWeerd

    Identifying the pro-survival functions of BIRC5 in T-ALL cells compared to normal healthy cells to inform the design of inhibitors.
  • Alessandra DiMauro

    Determining functional roles of CAF subtypes in leader cell directed collective migration
  • Haley Jane Hashemi Hashemi

    I am currently investigating the activity and stability of A3A isoforms, and how this may play a role in cancer associated DNA damage.
  • Omar Ibrahim

    Immunomodulation of the tumor microenvironment
  • Darya Khantakova

    Innate immune cells in the tumor microenvironment
  • Tim Kong (MSTP in PhD training)

    Pevonedistat target malignant cells in myeloproliferative neoplasms via NF-kB-pathway inhibition
  • Aishwarya Krishnan

    Understanding how APOBEC3A impacts transcript stability
  • Jie Liu

    Characterization of Genetic Predisposition to Clonal Hematopoiesis and Progression to Myeloid Neoplasms
  • Alex Mabry

    Modulating membrane receptor availability to improve antibody based therapies.
  • Hung Mai

    Characterization of DDX54 functions in breast cancers.
  • Camryn Marquez

    Determine the role of fibroblast subpopulations associated with cancer in promoting angiogenesis and evaluate senescence's effect on gene expression.
  • Isabelle Seppa

    My research is focused on what factors mediate MRE11 activity in single-stranded gap processing during the DNA damage response process.
  • Judith Sokei

    Understanding metabolic reprogramming in gynecological cancers with a focus on high grade serous ovarian (HGSOC) and the role/effect of GAS6/AXL signaling as a therapeutic strategy.
  • Luisangely Soto Torres

  • Infencia Xavier Raj

    Understanding how JARID2 works independent of PRC2.
   
Page    of 1

Follow us: